GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations

Guyatt, 2011, GRADE guidelines: 2. Framing the question and deciding on important outcomes, J Clin Epidemiol, 64, 395, 10.1016/j.jclinepi.2010.09.012 Guyatt, 2011, GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables, J Clin Epidemiol, 64, 383, 10.1016/j.jclinepi.2010.04.026 Guyatt, 2011, GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias), J Clin Epidemiol, 64, 407, 10.1016/j.jclinepi.2010.07.017 Balshem, 2011, Grade guidelines: 3 Rating the quality of evidence—introduction, J Clin Epidemiol, 64, 401, 10.1016/j.jclinepi.2010.07.015 Guyatt, 2011, Grade guidelines: 6. Rating the quality of evidence: imprecision, J Clin Epidemiol, 64, 1283, 10.1016/j.jclinepi.2011.01.012 Guyatt, 2011, GRADE guidelines: 5. Rating the quality of evidence—publication bias, J Clin Epidemiol, 64, 1277, 10.1016/j.jclinepi.2011.01.011 Guyatt, 2011, GRADE guidelines: 7. Rating the quality of evidence—inconsistency, J Clin Epidemiol, 64, 1294, 10.1016/j.jclinepi.2011.03.017 Guyatt, 2011, GRADE guidelines: 8. Rating the quality of evidence—indirectness, J Clin Epidemiol, 64, 1303, 10.1016/j.jclinepi.2011.04.014 Guyatt, 2011, GRADE guidelines: 9. Rating up the quality of evidence, J Clin Epidemiol, 64, 1311, 10.1016/j.jclinepi.2011.06.004 Guyatt, 2013, GRADE guidelines: 11. Making an overall rating of the quality of evidence for a single outcome and for all outcomes, J Clin Epidemiol, 66, 151, 10.1016/j.jclinepi.2012.01.006 Brunetti, 2013, GRADE guidelines 11. Special challenges: confidence in estimates for resource use, J Clin Epidemiol, 66, 140, 10.1016/j.jclinepi.2012.04.012 Guyatt, 2013, GRADE guidelines: 12. Preparing summary of findings tables: binary outcomes, J Clin Epidemiol, 66, 158, 10.1016/j.jclinepi.2012.01.012 Guyatt, 2013, GRADE guidelines: 13. Preparing summary of findings tables: continuous outcomes, J Clin Epidemiol, 66, 173, 10.1016/j.jclinepi.2012.08.001 Chong, 2011, What should we call weak recommendations?, Newsl Int Soc Evid Based Health Care, 2, 6 Akl, 2012, “Might” or “suggest”? No wording approach was clearly superior in conveying the strength of recommendation, J Clin Epidemiol, 65, 268, 10.1016/j.jclinepi.2011.08.001 Lomotan, 2010, How “should” we write guideline recommendations? Interpretation of deontic terminology in clinical practice guidelines: survey of the health services community, Qual Saf Health Care, 19, 509 Rothwell, 2005, External validity of randomised controlled trials: “to whom do the results of this trial apply?”, Lancet, 365, 82, 10.1016/S0140-6736(04)17670-8 Akl, 2007, Symbols were superior to numbers for presenting strength of recommendations to health care consumers: a randomized trial, J Clin Epidemiol, 60, 1298, 10.1016/j.jclinepi.2007.03.011 2009, Folic acid for the prevention of neural tube defects: U.S. Preventive Services Task Force recommendation statement, Ann Intern Med, 150, 626, 10.7326/0003-4819-150-9-200905050-00009 Wolff, 2009, Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S. Preventive Services Task Force, Ann Intern Med, 150, 632, 10.7326/0003-4819-150-9-200905050-00010 Whelan, 2003, Helping patients make informed choices: a randomized trial of a decision aid for adjuvant chemotherapy in lymph node-negative breast cancer, J Natl Cancer Inst, 95, 581, 10.1093/jnci/95.8.581 National Institute for Health and Clinical Excellence. Hip fracture: the management of hip fracture in adults. Clinical guideline 124. London, UK; National Institute for Health and Clinical Excellence; June 2011. Bates, 2008, Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition), Chest, 133, 844S, 10.1378/chest.08-0761 1996, A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee, Lancet, 348, 1329, 10.1016/S0140-6736(96)09457-3 Albers, 2004, Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy, Chest, 126, 483S, 10.1378/chest.126.3_suppl.483S Clagett, 2004, Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy, Chest, 126, 609S, 10.1378/chest.126.3_suppl.609S Spechler SJ, Achalaisa. In: UpToDate, Grover S, deputy editor, Basow DS, Editor. Waltham, MA; UpToDate; April 25, 2012. Albers, 2008, Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition), Chest, 133, 630S, 10.1378/chest.08-0720 Apfel, 1984 Dutton, 1988 Alfirevicm, 2006, Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour, Cochrane Database Syst Rev, 3, CD006066 Sibanda, 1975, Influence on clinical practice of routine intra-partum fetal monitoring, Br Med J, 3, 341, 10.1136/bmj.3.5979.341 Liston, 2007, Fetal Health Surveillance: antepartum and intrapartum consensus guideline, J Obstet Gynaecol Can, 29, S3, 10.1016/S1701-2163(16)32615-9 Brown, 2006, How to formulate research recommendations, Br Med J, 333, 804, 10.1136/bmj.38987.492014.94 Petitti, 2009, Update on the methods of the U.S. Preventive Services Task Force: insufficient evidence, Ann Intern Med, 150, 199, 10.7326/0003-4819-150-3-200902030-00010 Hussain, 2009, The Yale Guideline Recommendation Corpus: a representative sample of the knowledge content of guidelines, Int J Med Inform, 78, 354, 10.1016/j.ijmedinf.2008.11.001 Montori, 2008, Decision making and the patient